RUNX1 loss renders hematopoietic and leukemic cells dependent on interleukin-3 and sensitive to JAK inhibition
Fan AC. et al, (2023), Journal of Clinical Investigation
The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia
Nakauchi Y. et al, (2022), Blood Cancer Discovery
IL-3 SELECTIVELY RESCUES RUNX1-DEFICIENT HUMAN HSPCS WITH DYSREGULATED JAK/STAT SIGNALING
Fan A. et al, (2022), EXPERIMENTAL HEMATOLOGY, 111, S84 - S84
HYPERSENSITIVITY TO IL-3 RESCUES INFLAMMATORY RUNX1-DEFICIENT HUMAN HSPCS
Fan A. et al, (2021), EXPERIMENTAL HEMATOLOGY, 100, S48 - S48
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.
Labuhn M. et al, (2019), Cancer Cell, 36
MODELING THE PATHOGENESIS OF RUNX1 DEFICIENCY IN INHERITED AML PREDISPOSITION SYNDROMES IN PRIMARY CELLS
Fan A. et al, (2019), EXPERIMENTAL HEMATOLOGY, 76, S65 - S65
Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.
Bak RO. et al, (2018), Elife, 7
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
Bak RO. et al, (2017), ELIFE, 6